×
About 5,403 results

ALLMedicine™ Hyperkalemia Center

Research & Reviews  1,512 results

Hyperkalemia in a Hemolyzed Sample in Pediatric Patients: Repeat or Do Not Repeat?
https://doi.org/10.1097/PEC.0000000000002857
Pediatric Emergency Care; Kaila R, Hendrickson M et. al.

Oct 1st, 2022 - The aim of the study is to analyze whether repeat testing is necessary in healthy children presenting to a pediatric emergency department (ED) who are found to have hyperkalemia on a hemolyzed specimen. A 5-year retrospective analysis of pediatric...

Importance of Metabolic Acidosis as a Health Risk in Chronic Kidney Disease.
https://doi.org/10.1053/j.ackd.2022.05.002
Advances in Chronic Kidney Disease; Vincent-Johnson A, Scialla JJ

Sep 30th, 2022 - Human kidneys are well adapted to excrete the daily acid load from diet and metabolism in order to maintain homeostasis. In approximately 30% of patients with more advanced stages of CKD, these homeostatic processes are no longer adequate, resulti...

Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)
https://clinicaltrials.gov/ct2/show/NCT04847232

Sep 30th, 2022 - This is an international, multicenter, event-driven, randomized, double-blind, parallel group, placebo-controlled study, evaluating the utility of SZC versus placebo to reduce the incidence of sudden cardiac death (SCD), stroke, and arrhythmia-rel...

Tracking Treatment Pathways in Adult Patients With Hyperkalemia.
https://clinicaltrials.gov/ct2/show/NCT05408039

Sep 28th, 2022 - This study is a multinational, observational, prospective, longitudinal, cohort study that will include primary and secondary data collection. Secondary data, collected as per routine clinical practice will be extracted from electronic health reco...

Page phenomenon in a transplanted kidney: is it salvageable?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516073
BMJ Case Reports; Cisneros R, Nair A et. al.

Sep 27th, 2022 - A male in his late 70s with a history of an uncomplicated kidney transplantation 20 years prior was brought to the Emergency Department after experiencing blunt abdominal trauma following a motor vehicle collision. Imaging revealed a large perinep...

see more →

Guidelines  1 results

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood...
https://doi.org/10.1016/j.cjca.2016.02.066
The Canadian Journal of Cardiology; Leung AA, Nerenberg K et. al.

Apr 28th, 2016 - Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force provides annually updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present 4 ne...

see more →

Drugs  182 results see all →

Clinicaltrials.gov  138 results

Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)
https://clinicaltrials.gov/ct2/show/NCT04847232

Sep 30th, 2022 - This is an international, multicenter, event-driven, randomized, double-blind, parallel group, placebo-controlled study, evaluating the utility of SZC versus placebo to reduce the incidence of sudden cardiac death (SCD), stroke, and arrhythmia-rel...

Tracking Treatment Pathways in Adult Patients With Hyperkalemia.
https://clinicaltrials.gov/ct2/show/NCT05408039

Sep 28th, 2022 - This study is a multinational, observational, prospective, longitudinal, cohort study that will include primary and secondary data collection. Secondary data, collected as per routine clinical practice will be extracted from electronic health reco...

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
https://clinicaltrials.gov/ct2/show/NCT03087058

Sep 26th, 2022 - Up to 54 subjects, 2 - < 18 years of age with CKD (estimated glomerular filtration rate [eGFR] < 90 mL/min/1.73 m2 ) and hyperkalemia (two potassium measurements of 5.1 to < 6.5 mEq/L performed on separate days) will be enrolled in this open-label...

Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy
https://clinicaltrials.gov/ct2/show/NCT03502031

Sep 22nd, 2022 - NephroNet proposes to examine whether combining Spironolactone with maximal RAAS blockade will further reduce urinary protein at one year and whether prolonged therapy (24 months) is able to slow the decline in GFR. Because of combination MRA and ...

Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
https://clinicaltrials.gov/ct2/show/NCT05136664

Sep 16th, 2022 - In Part A, participants who meet all eligibility criteria will initiate patiromer at an oral dose of 8.4 g (1 packet/day). The dose will be adjusted based on the serum potassium (sK+) levels. After the completion of part A, all the participants wh...

see more →

News  327 results

Expert calls for thoughtful approach to curbing costs in dermatology
https://www.mdedge.com/dermatology/article/258171/business-medicine/expert-calls-thoughtful-approach-curbing-costs
Doug Brunk

Sep 22nd, 2022 - PORTLAND, ORE. – About 10 years ago when Arash Mostaghimi, MD, MPA, MPH, became an attending physician at Brigham and Women’s Hospital, Boston, he noticed that some of his dermatology colleagues checked the potassium levels religiously in their fe.

Discontinuation of Allopurinol for Tumor Lysis Syndrome Report
https://www.mdedge.com/fedprac/avaho/article/257554/hematology/discontinuation-allopurinol-tumor-lysis-syndrome-report
Yasmine Ayoub, Sara Gordon et. al.

Sep 2nd, 2022 - Background/Purpose Tumor lysis syndrome (TLS) is caused by the release of intracellular products into the blood following rapid lysis of malignant cells resulting in hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. Complications o.

Not Just Castleman Disease: an Elusive Diagnosis of TAFRO Syndrome
https://www.mdedge.com/fedprac/avaho/article/257528/oncology/not-just-castleman-disease-elusive-diagnosis-tafro-syndrome
Shashank Sama, Lindsey Fitzgerald et. al.

Sep 1st, 2022 - Introduction Idiopathic multicentric Castleman disease (iMCD) cases with thrombocytopenia (T), anasarca (A), Fever (F), reticulin fibrosis (R), and organomegaly (O) are considered a subtype of iMCS called TAFRO syndrome. It is a rare syndrome char.

Real-World Findings Support RASi Continuation in Advanced CKD
https://www.medscape.com/viewarticle/980033

Aug 31st, 2022 - The study covered in this summary was published in Preprints with The Lancet and has not yet been peer reviewed. Key Takeaways In a real-world study, discontinuing renin-angiotensin-system inhibitors (RASi) in patients with type 2 diabetes and adv...

Aug 5, 2022 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/978646

Aug 5th, 2022 - Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast on Apple Podcasts, Spotify, or your preferred podcast provider...

see more →

Patient Education  1 results see all →